The Université catholique de Louvain is Belgium's largest French-speaking university. It is located in Louvain-la-Neuve, which was expressly built to house the university, and Brussels, Charleroi, Mons, Tournai and Namur.

During the past decade, Universite Catholique de Louvain conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 4 clinical trials were completed, i.e. on average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Universite Catholique de Louvain" #1 sponsor was "Université Catholique de Louvain" with 7 trials, followed by "European Hepatocellular Cancer Liver Transplant Group" with 3 trials sponsored, "Gilead Sciences" with 2 trials sponsored, "Patrick Durez" with 2 trials sponsored and "Actelion" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universite Catholique de Louvain" #1 collaborator was "Fonds National de la Recherche Scientifique" with 2 trials as a collaborator, "Horizon 2020 - European Commission" with 1 trials as a collaborator, "Novartis" with 1 trials as a collaborator, "PRA Health Sciences" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Universite Catholique de Louvain" are "Alcoholism" (2 trials), "Liver Cancer" (2 trials), "Rheumatoid Arthritis" (2 trials), "Acute Graft-versus-Host Disease" (1 trials) and "Acute Myeloid Leukemia" (1 trials). Many other conditions were trialed in "Universite Catholique de Louvain" in a lesser frequency.

Most popular intervention types in "Universite Catholique de Louvain" are "Drug" (10 trials), "Procedure" (4 trials), "Other" (3 trials), "Behavioral" (2 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Liver transplantation" (2 trials), "Methotrexate" (2 trials), "Placebo" (2 trials), "placebo" (2 trials) and "Adaptive sports" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universite Catholique de Louvain" are 21 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Universite Catholique de Louvain". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Universite Catholique de Louvain, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Universite Catholique de Louvain, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 8 trials that are defined as “Not Applicable".

Universite Catholique de Louvain has several departments that took part in Clinical trials: "Institute of Neuroscience, Université catholique de Louvain" - 7 trials, "Department of Neurology, CHU Mont-Godinne" - 3 trials